COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Avid Radiopharmaceuticals develops molecular imaging agents and reagents for medical scans, focusing on early-detection neurodegenerative imaging (Alzheimer’s, Parkinson’s), including beta-amyloid-targeting AV-1.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors